PMAM
PRAH

Picton Mahoney Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Picton Mahoney Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-52,139
Closed -$8.61M – 1079
2021
Q2 		$8.61M Sell
52,139
-37,861
-42% -$6.32M 0.25% 83
2021
Q1 		$13.8M Buy
+90,000
New +$12.2M 0.66% 37
2020
Q1 		– Sell
-19,600
Closed -$2.18M – 361
2019
Q4 		$2.18M Sell
19,600
-7,600
-28% -$782K 0.15% 115
2019
Q3 		$2.7M Sell
27,200
-2,100
-7% -$209K 0.19% 104
2019
Q2 		$2.9M Sell
29,300
-1,600
-5% -$153K 0.2% 97
2019
Q1 		$3.41M Sell
30,900
-1,500
-5% -$157K 0.26% 88
2018
Q4 		$2.98M Sell
32,400
-800
-2% -$80.9K 0.27% 78
2018
Q3 		$3.66M Sell
33,200
-700
-2% -$72.9K 0.26% 85
2018
Q2 		$3.17M Sell
33,900
-9,500
-22% -$818K 0.23% 89
2018
Q1 		$3.6M Buy
43,400
+6,400
+17% +$569K 0.26% 97
2017
Q4 		$3.37M Buy
+37,000
New +$3.08M 0.24% 94

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Picton Mahoney Asset Management's PRAH Position: Q3 2021 in Review

Picton Mahoney Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 52,139 shares — an estimated $8.61M sold.

Picton Mahoney Asset Management first reported a position in PRAH in Q4 2017 and held it in 11 quarters. The position peaked at $13.8M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Picton Mahoney Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 52,139 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $8.61M.
  • Picton Mahoney Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 11 quarters.
  • Picton Mahoney Asset Management's PRA Health Sciences, Inc. position peaked at $13.8M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.